Auto-generated event page

KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS

STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycys...

Score 41 low confidence 1 source posts Updated Mar 3, 2026, 10:10 AM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS

GlobeNewswire Public Companies • Mar 3, 2026, 9:49 AM UTC

Entity focus

Direct link to post

https://pushme.site/signals/180211-kdventures-announces-that-organon-has-discontinued-the-development-of-th?utm_source=signal-180211&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub